U.S. Antimony adds CEO John Gustavsen and Timothy Hasara to board of directors

UNITED STATES ANTIMONY CORP

John Gustavsen, CEO since Oct 2011, appointed as director; formerly CEO of Amspec Chemical.
Timothy Hasara, founder of Sinnet Capital, appointed as director; previously managed $1B+ microcap fund.
Appointments effective August 4, 2022.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Gustavsen

Director

UAMY · UNITED STATES ANTIMONY CORP

Effective: 2022-08-04
Filed: August 5, 2022, 7:59 PM ET

U. S. Antimony is very pleased to announce two newly-appointed directors, John Gustavsen, CEO and Timothy Hasara.

Appointed

Timothy Hasara

Director

UAMY · UNITED STATES ANTIMONY CORP

Effective: 2022-08-04
Filed: August 5, 2022, 7:59 PM ET

U. S. Antimony is very pleased to announce two newly-appointed directors, John Gustavsen, CEO and Timothy Hasara.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Gustavsen was appointed as Director at UNITED STATES ANTIMONY CORP.

Action: appointed
Role: Director

Exact text from the filing

U. S. Antimony is very pleased to announce two newly-appointed directors, John Gustavsen, CEO and Timothy Hasara.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy Hasara was appointed as Director at UNITED STATES ANTIMONY CORP.

Action: appointed
Role: Director

Exact text from the filing

U. S. Antimony is very pleased to announce two newly-appointed directors, John Gustavsen, CEO and Timothy Hasara.

View on SEC.gov

UNITED STATES ANTIMONY CORP filing history →

Source: SEC EDGAR

accession 0001654954-22-010652

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.